Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia (ITIC2)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2013 by Medical University of Vienna
Sponsor:
Collaborators:
Medical University of Graz
Medical University Innsbruck
Krankenhaus Barmherzige Schwestern Linz
Salzburger Landeskliniken
Information provided by (Responsible Party):
Stephan Polterauer, Medical University of Vienna
ClinicalTrials.gov Identifier:
NCT01283763
First received: January 21, 2011
Last updated: July 15, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)